Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, ...
Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, 2025 SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) ...
fistula and at the venous anastomosis of a synthetic AV graft. Merit noted that since 2010, it has collaborated with Bart Dolmatch, MD, an interventional radiologist at Palo Alto Medical Foundation in ...
ExeGi Pharma LLC, a company focused on developing live biotherapeutic ("LBP") drugs and probiotics, announced positive topline results in the Phase 1b portion of its PROF study. The PROF study is ...
While they can be fixed, they’re an important factor to keep in mind when procedures that involve anastomosis are on the table. That way, early detection can lead to an easier fixing procedure.